Issue · Tuesday, 20 October 2026
Nasdaq +1.11% as AI credit fears ease; Amazon +5%, Cliffs +16%
Get this in your inbox at 07:00 CET every weekday. Free, 3 minutes, every number sourced.
Free · weekdays 07:00 CET · unsubscribe anytime
TL;DR
- Tech bounced back. The Nasdaq rose 1.11% and the S&P 500 0.41% as worries about debt-funded AI build-outs eased, while the Dow slipped 0.07%.
- Amazon led the big names, up almost 5% after Morgan Stanley named it a top pick.
- Rates are still the catch. The 10-year Treasury yield climbed to about 5.14% and WTI crude settled above $103.
📊 Indices (close, Mon 19 Oct)
| Index | Close | Change |
|---|---|---|
| Dow Jones | 51,966.03 | −36.38 (−0.07%) |
| S&P 500 | 7,690.73 | +31.29 (+0.41%) |
| Nasdaq Composite | 26,430.89 | +290.85 (+1.11%) |
Also: breadth was weak under the surface, with 317 S&P 500 stocks down and only 170 up. WTI settled at $103.66 (+2.22%) while Brent slipped 0.28% to $109.55.
🪙 Crypto (Tue morning)
- Bitcoin: about $82,050, down about 0.5% over 24h.
- Ether: about $2,410, down about 0.4% over 24h.
- Crypto sat out the tech bounce, much as it sat out last week's slide.
🚀 Movers
- Amazon (AMZN) +4.98% to $262.45. Morgan Stanley made it a top pick and raised its target to $350 from $335, citing faster AWS growth. Amazon also unveiled TorchNeuron (more below).
- Cleveland-Cliffs (CLF) +16.3% to $14.10. Q3 adjusted EBITDA of $612M beat its own $575M guidance, and the steelmaker now expects 2027 adjusted EBITDA above $4B.
- Silence Therapeutics (SLN) +125.6% to $19.58. Merck KGaA agreed to buy it for $20 per ADS in cash, about $1.3B in equity value, for divesiran, its experimental drug for a rare blood cancer.
- Disc Medicine (IRON) +38.9% to $78.93. Its pill bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for a rare light-sensitivity disorder.
- Chips steadied: Micron +2.97% and Nvidia +1.38% after last week's heavy selling.
🤖 AI/Tech story: OpenAI races Anthropic for cash
Reuters reports that OpenAI is rushing to line up a roughly $30B funding round before Anthropic's expected mid-November IPO, at a valuation that could top $1.4 trillion. SoftBank and MGX are in talks to join. OpenAI is telling investors it has reached $50B in annualized revenue and expects $70B by year-end. Separately, Amazon launched TorchNeuron, free open-source software that lets its Trainium AI chips run PyTorch code without rewriting it, a direct shot at Nvidia's software lead.
👀 What to watch today (times CEST)
- Before the US open: GE Aerospace, RTX, 3M, General Motors, Northrop Grumman, Halliburton and Hasbro report.
- 14:30: US housing starts and building permits for September.
- After the US close (22:01): Netflix reports, with Intuitive Surgical, Capital One and United Airlines also out tonight.
- Later this week: Meta, Tesla and IBM (Wed), P&G and jobless claims (Thu), then consumer sentiment (Fri).
Sources: WSJ, "U.S. Stocks Mostly Higher as AI Credit Worries Abate" (19 Oct); Exa market data (DJI/SPX/IXIC, 19 Oct); TechCortex S&P 500 movers (19 Oct); Morningstar/Dow Jones 10-year yield data; CNBC bonds report (19 Oct); Yahoo Finance and CNBC on Morgan Stanley's Amazon call; Reuters via Investing.com on TorchNeuron and on OpenAI's fundraising (19 Oct); Cleveland-Cliffs Q3 2026 release; WSJ and Motley Fool on CLF; Merck KGaA and Silence Therapeutics releases (19 Oct); Market Chameleon movers (19 Oct); Disc Medicine APOLLO release and RTTNews; CoinGecko prices (20 Oct, 06:28 CEST); StockTitan earnings and economic calendar, week of 19 Oct.
For informational and educational purposes only. Not financial advice. Do your own research.
Get this in your inbox every weekday
Free · weekdays 07:00 CET · unsubscribe anytime